The Genetics of Pain: Science, Medicine, and Drug Development

 

The IASP SIG on Genetics and Pain

is pleased to announce

 

our SIG-Supported Satellite Symposium, 

Milan, Italy, August 26, 2012

 

SS 04: Current Concepts, Methods and Progress 

in Pain Genetics Research

 

For more information, please visit http://www.iasp-pain.org/Content/NavigationMenu/WorldCongressonPain2/14thWorldCongressonPain/CongressSchedule/Satellite_Symposia/default.htm


or view the program below. 

Thanks to all of our attendees, speakers, exhibitors, and sponsors, the Symposium was a great success. Attendees from 19 countries, all with a common interest in pain genetics, discussed the current state of the field and aspirations for the future.

 

We have begun to update the site with pictures, abstracts, and other news, so please visit us for updates on the Symposium, as well as other conferences and information specific to the field of pain genetics.

 

Thank you again to everyone who was a part of the Symposium. We are truly glad that you joined us, and we hope to see you again soon!

The International Association for the Study of Pain (IASP) 10th Research Symposium was presented on February 7-9, 2012 in Miami Beach, Florida. The Genetics of Pain: Science, Medicine, and Drug Development was the first in-kind program on pain genetics, featuring world-renowned leaders in the field.

 

During this IASP symposium we:

  • Discussed key issues in pain research, including promising ongoing research, unanswered questions, emerging concepts

  • Emphasized translational research as the key to understanding mechanisms of susceptibility to chronic pain, developing preventative approaches and novel treatment strategies

  • Explored the latest findings of genetic and genomic mediation of nociception from various models, emphasizing the conservation of pain-related genes, their functions and their advantages

  • Discussed the role of gene polymorphisms in normal and pathological modulation of pain in models, humans, and as future drug targets

  • Explored the latest findings from human genome-wide investigation of genomic variability and gene expression on pain and nociception

  • Reviewed and discuss “gold standard” tools for comprehensive pain phenotyping in humans

  • Reviewed and discuss current and future genetic and genomic techniques to study genetic contribution to human pain

  • Summarized the progress of cutting-edge clinical trials and those steps required to translate present research findings to clinical practice

  • Created a forum for the exchange of ideas on the impact of modern genetics on pain research

Keynote speakers include:


Marshall Devor
Hebrew University of Jerusalem, Israel

Roger Fillingim
University of Florida, USA

Henrik Kehlet
Copenhagen University, Denmark

Jörn Lötsch
W. Goethe-University, Frankfurt am Main, Germany

William Maixner
University of North Carolina, USA

Jeffrey Mogil
McGill University, Montreal, Canada

Christopher Nielsen
Norwegian Institute of Public Health, Oslo, Norway

Josef Penninger
Austrian Academy of Sciences, Vienna, Austria

Ze'ev Seltzer
University of Toronto, Canada

Clifford Woolf
Children's Hospital, Harvard University, Boston, USA